Detection of ganglioside M1 (GM1) antibodies, usually of the IgM isotype, is associated with multi-focal motor neuropathy and lower motor neuropathy, characterized by muscle weakness and atrophy. Multi-focal motor neuropathy may occur with or without high serum titers of anti-GM1 antibodies. GM1 antibodies are detected in approximately 50 % of persons with multi-focal motor neuropathy.
What is multi-focal motor neuropathy?
Multifocal motor neuropathy is a progressive muscle disorder characterized by weakness in the hands, with differences from one side of the body to the other in the specific muscles involved. It affects men much more than women. Symptoms also include:
The disorder is sometimes mistaken for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. But unlike ALS, multifocal motor neuropathy is treatable. An early and accurate diagnosis allows individuals to recover quickly.
Treatment for multifocal motor neuropathy varies. Some people experience only mild symptoms and do not require treatment. For others, treatment generally consists of intravenous immunoglobulin (IVIg) or immunosuppressive therapy with cyclophosphamide.
Improvement in muscle strength usually begins within three to six weeks after treatment is started. Most who receive treatment early experience little, if any, disability. However, there is evidence of slow progression over many years.
References:
Understand and improve your laboratory results with our health dashboard.
Upload your lab reports and get your interpretation today.
Our technology helps to understand, combine, track, organize, and act on your medical lab test results.
Detection of ganglioside M1 (GM1) antibodies, usually of the IgM isotype, is associated with multi-focal motor neuropathy and lower motor neuropathy, characterized by muscle weakness and atrophy. Multi-focal motor neuropathy may occur with or without high serum titers of anti-GM1 antibodies. GM1 antibodies are detected in approximately 50 % of persons with multi-focal motor neuropathy.
Interpret Your Lab Results
Upload your lab report, and we'll interpret and provide you with recommendations today.
Get StartedOur specialized data entry service is designed to seamlessly integrate your laboratory results into your private dashboard. Just send in your lab test results—whether it's an image or a file—and our skilled data entry team will handle the rest. We accommodate various file formats like PDFs, JPGs, and Excel.
The first report is complimentary. After that, the data entry service is priced at $15 per report, unless it's part of your subscribed plan. It's an ideal solution whether you have numerous reports to upload or if your schedule doesn't permit self-data entry.
We strive to make the data entry process easy for you. Whether by offering dozens of templates to choose from that pre-populate the most popular laboratory panels or by giving you instant feedback on the entered values. Our data entry forms are an easy, fast, and convenient way to enter the reports yourself. There is no limit on how many lab reports you can upload.
Personal plans
track personal results
Professional Plan
track multiple client's results
$15/month
$250/once
own it for life
$45/month
for health professionals
Personal Account
$15/month
for personal lab results
$250/once
own it for life
Level up your lab report analysis with our Pro plan, built for health practitioners like you.
Health Business Account
$45/month
Unlock additional Pro plans when you sign up.
At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.
Anti-Acetylcholine receptors (IgG + IgA), Anti-Acetylcholine receptors (IgM), Anti-Amphiphysin (IgG + IgA), Anti-Amphiphysin (IgM), Anti-Aquaporin 4 (IgG + IgA), Anti-Aquaporin 4 (IgM), Anti-Cerebellum (IgM), Anti-Contactin-associated protein-like 2 antibodies (IgG + IgA), Anti-Contactin-associated protein-like 2 antibodies (IgM), Anti-CV2 (IgG + IgA), Anti-CV2 (IgM), Anti-Endothelin A receptor (IgM), Anti-Glial fibrillary acidic protein (IgG + IgA), Anti-Glial fibrillary acidic protein (IgM), Anti-Glucose regulated protein 78 (IgG + IgA), Anti-Glucose regulated protein 78 (IgM), Anti-Glycine receptor (IgG + IgA), Anti-Glycine receptor (IgM), Anti-GM1 (IgG + IgA), Anti-GM1 (IgM), Anti-GM2 (IgG + IgA), Anti-GM2 (IgM), Anti-Hu (IgG + IgA), Anti-Hu (IgM), Anti-Hydroxytryptamine (IgM), Anti-MAG (IgG + IgA), Anti-MAG (IgM), Anti-Microglia (IgG + IgA), Anti-Microglia (IgM), Anti-Muscle specific kinase (IgG + IgA), Anti-Muscle specific kinase (IgM), Anti-Myelin basic protein (IgG + IgA), Anti-Myelin basic protein (IgM), Anti-Myelin oligodendrocyte glycoprotein (IgG + IgA), Anti-Myelin oligodendrocyte glycoprotein (IgM), Anti-Myelin proteolipid protein (IgG + IgA), Anti-Myelin proteolipid protein (IgM), Anti-Neurofascin (IgG + IgA), Anti-Neurofascin (IgM), Anti-Neuron specific enolase (IgG + IgA), Anti-Neuron specific enolase (IgM), Anti-Purkinje cell, Anti-Recoverin (IgG + IgA), Anti-Recoverin (IgM), Anti-Ri (IgG + IgA), Anti-Ri (IgM), Anti-s100b (IgG + IgA), Anti-s100b (IgM), Anti-Streptococcal A (IgG), Anti-Tubulin (IgG + IgA), Anti-Tubulin (IgM), Anti-Voltage gated calcium channels (IgG + IgA), EBNA1 (IgG), p18 (IgG), VCA gp125 (IgG)